论文部分内容阅读
目的:探讨肾炎康复片治疗2型糖尿病早中期肾病患者的临床疗效。方法:分析2015年5月-2016年5月间我院接收的60例糖尿病肾病患者,将患者随机分为对照组30例,治疗组30例,对照组予以控制蛋白摄入、降糖、降脂治疗,治疗组在上述基础上联合肾炎康复片治疗,观察治疗6月后疗效变化。结果:经治疗后,两24h尿蛋白、血肌酐、血尿素氮均得到一定改善,且组间差异有统计学意义(P<0.05);研究组总有效率90.0%,对照组总有效率66.7%,两组之间差异明显(P<0.05)。结论:肾炎康复片能够改善2型糖尿病患者早中期症状,能减少尿蛋白排泄,能够延缓终末期肾病的进展。
Objective: To investigate the clinical effect of nephritis Kangsipian tablet in the treatment of type 2 diabetes mellitus patients with early-mid stage nephropathy. Methods: From May 2015 to May 2016, 60 patients with diabetic nephropathy received in our hospital were randomly divided into control group (n = 30) and treatment group (n = 30). The control group was given control protein intake, hypoglycemic, Lipid treatment, the treatment group on the basis of the above combination of nephritis and rehabilitation tablets to observe the therapeutic effect after 6 months of treatment. Results: After treatment, urinary protein, serum creatinine and blood urea nitrogen in two groups all improved to some extent, and the difference between the two groups was statistically significant (P <0.05). The total effective rate was 90.0% in the study group and 66.7% in the control group %, Significant difference between the two groups (P <0.05). Conclusion: ShenYangKang tablet can improve the symptoms of early-middle stage in patients with type 2 diabetes, reduce urinary protein excretion and delay the progress of end-stage renal disease.